Moreover, incubation of multiple myeloma cells with doxorubicin or the alkylating agent melphalan can lead to the robust activation of NF-κB activity that confers anti-apoptotic abilities to the treated cells [41]. The gene discussed is NFKB1; the disease is AL amyloidosis.